Thomson Reuters Corp (TRI.N)
19 Dec 2014
|Market Cap (Mil.):||$31,870.06|
|Shares Outstanding (Mil.):||799.69|
(Corrects lead to show Alibaba Group affiliate, not Alibaba itself agreed the investment)
- Eli Lilly and Co said its quarterly earnings plunged 58 percent, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its full-year profit forecast.
- U.S. medical equipment maker Medtronic Inc said it would still buy Covidien Plc but would use $16 billion in debt rather than cash held overseas, reacting to new U.S. Treasury guidelines designed to cut the benefits of such "inversion deals."
NEW YORK, Oct 3 (IFR) - JP Morgan has teamed up with unregulated lenders to underwrite a highly leveraged buyout financing for the acquisition of business software maker Tibco, which market sources said could contravene regulatory guidelines on risky lending.
|International Business Machines Corp. (IBM.N)||$158.51||+0.83|
|Google Inc (GOOGL.OQ)||$520.04||+5.42|
|Google Inc (GOOG.OQ)||$516.35||+5.25|
|RR Donnelley & Sons Co (RRD.OQ)||$16.72||+0.28|
|McGraw Hill Financial Inc (MHFI.N)||$90.05||-0.79|
|Intuit Inc. (INTU.OQ)||$93.92||-0.56|
|Reed Elsevier NV (ELSN.AS)||€19.28||+0.00|
|Wolters Kluwer (WLSNc.AS)||€24.86||+0.22|
|Reed Elsevier plc (REL.L)||1,078.00p||-2.00|
|ICAP plc (IAP.L)||449.40p||+4.30|